NASDAQ · Drug Manufacturers - Specialty & Generic

VTRS (VTRS) Stock

$16.63 +0.73% NASDAQ: VTRS Healthcare

Valuation

MetricValue
Price$16.63
Market Cap$19.37B
P/E Ratio-45.39
P/B Ratio1.33
P/S Ratio1.29
EPS (TTM)$-0.30
52-Week High$18.39
52-Week Low$9.43
Dividend Yield2.94%

Financials & Margins

MetricValue
ROE-2.79%
ROA-1.17%
ROCE-0.30%
Gross Margin39.82%
Operating Margin6.78%
Net Margin-2.79%
Debt/Equity0.96
Current Ratio1.60

Annual Financials (USD)

Metric20212022202320242025
Revenue$17.9B$16.3B$15.4B$14.7B$14.3B
Operating Profit$-34.0M$1.6B$766.0M$10.0M$-2.7B
Net Profit$-1.3B$2.1B$55.0M$-634.0M$-3.5B
EPS$-1.05$1.71$0.05$-0.53$-3.00
Op Margin-0.2%9.9%5.0%0.1%-18.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$54.8B$50.0B$47.7B$41.5B$37.2B
Total Liabilities$34.4B$28.9B$27.2B$22.9B$22.5B
Cash$701.0M$1.3B$992.0M$735.0M$1.3B
Borrowings$23.4B$19.5B$18.4B$14.3B$14.7B

Latest News

VTRS or DHR: Which Is the Better Value Stock Right Now? Zacks · Jul 9, 2026 Systemic Lupus Erythematosus Market at a Turning Point as 6 Late-Stage Emerging Therapies Set to Redefine Treatment Landscape | DelveInsight PR Newswire · Jul 9, 2026 Should Value Investors Buy Viatris (VTRS) Stock? Zacks · Jul 9, 2026 3 Dirt Cheap Healthcare Shares Under $30 to Buy Right Now 24/7 Wall St. · Jul 7, 2026 Should Viatris’ Japan IgA Nephropathy Win and New Loan Shape VTRS Investors’ Next Move? Simply Wall St. · Jul 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$3.0B$3.0B$2.8B$2.3B$2.3B
Investing Cash Flow$-627.0M$985.0M$-1.2B$1.5B$-806.0M
Financing Cash Flow$-514.0M$-19.0M$-480.0M$-44.0M$-735.0M
Net Cash Flow$-144.0M$556.0M$-269.0M$-257.0M$612.0M
Free Cash Flow$2.5B$2.5B$2.3B$2.0B$1.9B

Valuation & Return Ratios

MetricValue
PEG Ratio-3.11
EV / EBITDA12.03
FCF Yield9.84%
Quick Ratio0.96
Interest Coverage-0.18
Return 1Y62.53%
Return 3Y68.49%
Return 5Y44.70%

Ownership

Insiders Held0.31%
Institutions Held88.26%
Institutions Float Held88.54%
Institutional HolderSharesReport Date
Blackrock Inc.84,359,8042026-03-31
Davis Selected Advisers78,211,1912026-03-31
Vanguard Capital Management LLC74,716,6312026-03-31
Price (T.Rowe) Associates Inc65,864,1042026-03-31
Vanguard Portfolio Management LLC53,911,2372026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BAX $25.48 -2.00% -12.99 $13.17B 0.15%
BBIO $76.57 -0.03% -22.17 $15.00B 0.00%
ELAN $23.91 -0.04% -42.77 $11.94B 0.00%
EXASExact Sciences Corporation $104.91 -95.37 $20.03B 0.00%
IONS $59.88 -0.80% -41.80 $9.95B 0.00%

About VTRS

VTRS is led by CEO Scott Andrew Smith, employs 30,000 people, headquartered in Canonsburg, US, publicly traded since 1980.

VTRS stock trades at $16.63 with a market capitalization of $19.37B. The stock is valued at a price-to-earnings (P/E) ratio of -45.39, price-to-book of 1.33, price-to-sales of 1.29. Over the past 52 weeks the stock has ranged between $9.43 and $18.39, and currently trades 9.6% below its 52-week high. It pays a dividend yielding 2.94%.

On profitability, VTRS generates a return on equity (ROE) of -2.79%, return on capital employed of -0.30%, an operating margin of 6.78%, a net profit margin of -2.79%.

In its most recent fiscal year, VTRS reported annual revenue of $14.3B, net profit of $-3.5B, revenue has compounded at 3.7% a year over the last five years.

The balance sheet shows a debt-to-equity ratio of 0.96, a current ratio of 1.60, total assets of $37.2B, $1.3B in cash and equivalents.

VTRS has a beta of 0.89.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides